The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
1471 CLINDAMAN GEL EACH 100G CONTAINS: CLINDAMYCIN HYDROCHLORIDE 1.25 G EQ.TO CLINDAMYCIN 1G GEL TUBE TOPICAL APPLICATION IN THE TREATMENT OF ACNE VULGARIS NULL LAO INTER PHARMA CO.,LTD T MAN PHARMA COMPANY LIMITED THAILAND CERTIFICATE RELEASED 07 I 5240/22 17-Aug-2022 16-Aug-2025 View
1472 CONHEXZINE SYRUP BROMHEXINE HCL 4 MG/5 ML SYRUP Bottle AS A MUCOLYTIC IN THE MANAGEMENT OF VISCID MUCOID SECRETIONS ASSOCIATED WITH BRONCHITIS, BRONCHIECTASIS, SINUSITIS NULL LAO INTER PHARMA CO.,LTD CONTINENTAL-PHARM CO., LTD THAILAND CERTIFICATE RELEASED 10 I 4604/18 10-FEB-2025 09-FEB-2030 View
1473 DICLOXA RX 500 DICLOXACILLIN SODIUM 566 MG EQ. TO DICLOXACILLIN 500 MG CAPSULE ALU-PVC SHARE THE USES OF OTHER PENICILLINASE-RESISTANT PENICILLINS AND GENERALLY IS USED ONLY IN THE TREATMENT OF INFECTIONS CAUSED BY, OR SUSPECTED OF BEING CAUSED BY SUSCEPTIBLE PENICILLINASE -RESISTANT STAPHYLOCOCCI NULL LAO INTER PHARMA CO.,LTD R X MANUFACTURING CO.,LTD THAILAND CERTIFICATE RELEASED 05 I 5106/21 07-FEB-2025 06-FEB-2030 View
1474 DOPROCT OINTMENT HYDROCORTISONE ACETATE 5 G, ZINC OXIDE 200 MG, BENZOCAINE 10 MG OINTMENT TUBE EXTERNAL HAEMORRHOIDS, ITCHING PROCTITIS NULL LAO INTER PHARMA CO.,LTD CONTINENTAL-PHARM CO., LTD THAILAND CERTIFICATE RELEASED 06 I 3553/11 19-Apr-2023 18-Apr-2026 View
1475 DOPROCT SUPPOSITORY HYDROCORTISONE ACETATE 7.5 MG, ZINC OXIDE 250 MG, BENZOCAINE 40MG SUPPOSITORY PVC/PE STRIP INTERNAL AND EXTERNAL HAEMORRHOIDS, ITCHING PROCTITIS NULL LAO INTER PHARMA CO.,LTD CONTINENTAL-PHARM CO., LTD THAILAND CERTIFICATE RELEASED 06 I 3551/11 19-Apr-2023 18-Apr-2026 View
1476 ENAX ENOXAPARIN SODIUM BP 60 MG/0.6 ML SOLUTION FOR INJECTION SYRINGE THE PROPHYLAXIS OF THROMBOEMBOLIC DISORDERS OF VENOUS ORIGIN, IN PARTICULAR THOSE WHICH MAY BE ASSOCIATED WITH ORTHOPAEDIC OR GENERAL SURGERY, PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS BEDRIDDEN DUE TO ACUTE ILLNESSES INCLUDING CARDIAC INSUFFICIENCY, RESPIRATORY FAILURE, SEVERE INFECTION NULL LAO INTER PHARMA CO.,LTD HEALTH BIOTECH LTD INDIA CERTIFICATE RELEASED 07 I 5786/24 26-Jul-2024 25-Jul-2027 View
1477 ENAX ENOXAPARIN SODIUM BP 40 MG/0.4 ML SOLUTION FOR INJECTION SYRINGE THE PROPHYLAXIS OF THROMBOEMBOLIC DISORDERS OF VENOUS ORIGIN, IN PARTICULAR THOSE WHICH MAY BE ASSOCIATED WITH ORTHOPAEDIC OR GENERAL SURGERY, PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS BEDRIDDEN DUE TO ACUTE ILLNESSES INCLUDING CARDIAC INSUFFICIENCY, RESPIRATORY FAILURE, SEVERE INFECTION NULL LAO INTER PHARMA CO.,LTD HEALTH BIOTECH LTD INDIA CERTIFICATE RELEASED 04 I 4683/19 07-FEB-2024 06-FEB-2027 View
1478 EPHEVER EPHEDRINE HYDROCHLORIDE BP 30 MG/ML SOLUTION FOR INJECTION AMPOULES TREATMENT OF HYPOTENSION FROM SPINAL OR EPIDURAL ANAESTHESIA NULL LAO INTER PHARMA CO.,LTD VERVE HUMAN CARE LABOLATORIES INDIA CERTIFICATE RELEASED 12 I 4860/19 26-AUG-2024 25-AUG-2027 View
1479 ESOME CAPSULES 20 MG ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EQ.TO ESOMEPRAZOLE 20 MG CAPSULE BLISTERPACK ESOME ( ESOMEPRAZOLE ) IS INDICATED FOR GASTROESOPHAGEAL REFLUX DISEASE, AS A TRIPLE THERAPY( ESOMEPRAZOLE PLUS AMOXICILLIN AND CLARITHROMYCIN) FOR THE ERADICATION OF HELICOBACTER PYLORI, PATIENTS REQUIRING CONTINUOUS NSAID THERAPY, LONG TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS. NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 10 I 2581/11 10-Feb-2023 09-Feb-2026 View
1480 ESOME CAPSULES 40 MG ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EQ.TO ESOMEPRAZOLE 40 MG CAPSULE BLISTERPACK ESOME ( ESOMEPRAZOLE ) IS INDICATED FOR GASTROESOPHAGEAL REFLUX DISEASE, AS A TRIPLE THERAPY( ESOMEPRAZOLE PLUS AMOXICILLIN AND CLARITHROMYCIN) FOR THE ERADICATION OF HELICOBACTER PYLORI, PATIENTS REQUIRING CONTINUOUS NSAID THERAPY, LONG TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS. NULL LAO INTER PHARMA CO.,LTD GETZ PHARMA (PRIVATE) LIMITED PAKISTAN CERTIFICATE RELEASED 10 I 3580/11 10-Feb-2023 09-Feb-2026 View